A microglia-focused company dedicated to improving the lives of patients caregivers and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease.
Lead Underwriter
Guggenheim Securities, LLC, Jefferies LLC, Morgan Stanley & Co. LLC, Stifel Nicolaus & Company, Incorporated
